SOPHiA GENETICS (SOPH) Cash from Discontinued Operations (2021 - 2026)
SOPHiA GENETICS's (SOPH) quarterly Cash from Discontinued Operations came in at -$15.1 million in Q1 2026, down 40.65% year-over-year from -$25.5 million in Q1 2025, and down 40.65% quarter-over-quarter from -$10.8 million in Q1 2025.
Powered by 
Analysis
SOPHiA GENETICS (SOPH) Cash from Discontinued Operations (2021 - 2026) Analysis & Trends
SOPHiA GENETICS has disclosed Cash from Discontinued Operations across 6 years of filings, most recently posting -$15.1 million for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn | - |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn | - |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn | - |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn | - |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn | - |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn | - |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn | - |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn | - |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn | - |
| 10 | SOPHiA GENETICS | 554.05 Mn | 446.39 Mn | 15.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -15.12 Mn |
| Mar 31, 2025 | -10.75 Mn |
| Mar 31, 2024 | -14.65 Mn |
| Mar 31, 2023 | -14.79 Mn |
| Sep 30, 2022 | -22.82 Mn |
| Jun 30, 2022 | -19.55 Mn |
| Mar 31, 2022 | -17.40 Mn |
| Sep 30, 2021 | -16.18 Mn |
| Jun 30, 2021 | -16.22 Mn |
| Mar 31, 2021 | -10.12 Mn |